Evidence map›Paper›PMID 37675394›Full record

ReviewFrontiers in pediatrics2023

Can CD34

Weronika Stolpa, Agnieszka Mizia-Malarz, Magdalena Zapała, Bartosz Zwiernik

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Weronika StolpaDepartment of Oncology, Hematology, and Chemotherapy, Upper Silesia Children's Care Health Centre, Katowice, Poland.
Agnieszka Mizia-MalarzDepartment of Oncology, Hematology, and Chemotherapy, Upper Silesia Children's Care Health Centre, Katowice, Poland.
Magdalena ZapałaStudents' Research Group, Department of Pediatrics, Medical University of Silesia, Katowice, Poland.
Bartosz ZwiernikStudents' Research Group, Department of Pediatrics, Medical University of Silesia, Katowice, Poland.
Medical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: CD34 Objective: The study objective was to assess the prognostic role of CD34 Methods: 115 patients with BCP-ALL, the median age of 4.5 years (range 1.5-17.9 years), gender: female 63 (54.8%) with BCP-ALL were enrolled; Group I ( Results: A worse response on Days 8, 15, and 33 of therapy and at the end of treatment in Group II (CD34 Conclusions: 1.In BCP-ALL in children, the presence of CD34

Indexed as

acute lymphoblastic leukemiaB-cell precursorsCD34CD38childrenprognostic factor

Identifiers

PMID37675394
PMCPMC10478575
OpenAlexW4386072649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.